Product Details

Campral

Acamprosate Calcium
333 mg
DR Tablet


DIN/PIN/NPN

02293269

Manufacturer

Mylan Pharmaceuticals ULC

Formulary Listing Date

2018-06-29  

Unit Price

0.9601

Amount MOH Pays

0.9601

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N07BB03

Interchangeable Products

NO  

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
531 1 year

For the treatment of alcohol use disorder in patients who:

- Meet clinical criteria for alcohol use disorder; and

- Express a commitment to abstain from alcohol; and

- Have been abstinent from alcohol for at least 3 days prior to starting acamprosate; and

- Have confirmed participation in counselling and treatment for alcohol use disorder*

* An individualized treatment plan will have one or more of the following components: Counselling and follow-up with the patient's family physician, addiction physician, or psychiatrist; self-help groups such as Alcoholics Anonymous; and outpatient, day, or inpatient psychosocial rehabilitation programs.

 

EAP Criteria

NO

Product Monograph

View Monograph